GT Biopharma (GTBP) Return on Assets [ROA] (2011 - 2026)
GT Biopharma (GTBP) recorded Return on Assets [ROA] of -146.32% in Q1 2026, up 228.52 percentage points from -374.83% a year earlier and up 51.62 percentage points from the prior quarter.
GT Biopharma (GTBP) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, GT Biopharma reported Return on Assets [ROA] of -201.43%, down 49.18 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of +732.90 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -152.25% in FY2024 (-67.90 pp), -84.35% in FY2023 (+1.42 pp), -85.77% in FY2022 (+220.93 pp) and -306.70% in FY2021 (+627.62 pp).
- The Q1 2026 figure is the highest quarterly Return on Assets [ROA] since Q1 2024.
- On a year-over-year basis, Return on Assets [ROA] rose in two of the last four quarters, with an average year-over-year change of -38.41 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 4630.53 percentage points in Q2 2021, against a drop of 790.42 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -197.94% (Q4 2025), -182.18% (Q3 2025) and -216.46% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | GT Biopharma | 8.73 Mn | 8.73 Mn | - | -146.32% |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -146.32% |
| Dec 31, 2025 | -197.94% |
| Sep 30, 2025 | -182.18% |
| Jun 30, 2025 | -216.46% |
| Mar 31, 2025 | -374.83% |
| Dec 31, 2024 | -254.06% |
| Mar 31, 2024 | -103.45% |
| Dec 31, 2023 | -87.18% |
| Sep 30, 2023 | -93.43% |
| Jun 30, 2023 | -105.34% |
| Mar 31, 2023 | -106.07% |
| Dec 31, 2022 | -112.45% |
| Sep 30, 2022 | -148.86% |
| Jun 30, 2022 | -80.20% |
| Mar 31, 2022 | -44.63% |
| Dec 31, 2021 | -110.52% |
| Sep 30, 2021 | 3.20% |
| Jun 30, 2021 | -8.35% |
| Mar 31, 2021 | -33.80% |
| Dec 31, 2020 | 679.90% |
GT Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();